Calcium Polycarbophil
/api/v1/drug/calcium-polycarbophilMechanism of action
Sourced from openFDAMechanism-of-action class: Stool Bulking Activity.
Indications
Sourced from openFDA- USES relieves occasional constipation to help restore and maintain regularity this product generally produces bowel movement in 12 to 72 hoursICD-10: K59.00
Dosage & administration
Sourced from openFDADIRECTIONS take each dose of this product with at least 8 ounces (a full glass) of water or other fluid. Taking this product without enough liquid may cause choking. (See choking warning). this product works naturally so continued use for one to three days is normally required to provide full benefit. Dosage may vary according to diet, exercise, previous laxative use or severity of constipation. Age Recommended dose Daily maximum adults & children 12 years of age and over 2 caplets once a day up to 4 times a day children under 12 years consult a physician
Warnings & precautions
Sourced from openFDAChoking Warning: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention. Ask a doctor before use if you have abdominal pain, nausea, or vomiting a sudden change in bowel habits that persists over a period of 2 weeks Ask your doctor or pharmacist before use if you are taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work. When using this product do not use for more than 7 days unless directed by a doctor do not take more than 8 tablets in a 24 hour period unless directed by a doctor Stop use and ask a doctor if rectal bleeding occurs or if you fail to have a bowel movement after use of this or any other laxative. These could be signs of a serious condition. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.
Overdosage
Sourced from openFDAIn case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.
FAERS reports
- 1Fatigue2297.9%
- 2Diarrhoea2197.5%
- 3Constipation2057.0%
- 4Fall2006.9%
- 5Pain1946.7%
- 6Nausea1866.4%
- 7Dyspnoea1615.5%
- 8Headache1545.3%
- 9Drug Ineffective1505.1%
- 10Off Label Use1404.8%
- 11Dizziness1314.5%
- 12Asthenia1214.2%
- 13Death1143.9%
- 14Hypotension1113.8%
- 15Weight Decreased1053.6%
Clinical trials
The 10 most recently updated of 13 ClinicalTrials.gov registrations naming Calcium Polycarbophil as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- WISH, Feasibility of a Factorial DesignCompleted · Interventional · 18 enrolled · The University of Tennessee, KnoxvilleNCT07023822updated 2026-05-05
- Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase InhibitorsTerminated · Phase 2 · Interventional · 8 enrolled · University of ArkansasNCT04493333updated 2024-11-27
- Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive PatientsCompleted · Observational · 533 enrolled · Uriach Consumer HealthcareNCT06199128updated 2024-01-10
- Randomized Trial of Maternal Progesterone TherapyCompleted · Phase 2 · Interventional · 102 enrolled · Children's Hospital of PhiladelphiaNCT02133573updated 2023-08-09
- Sexual Absorption of Vaginal ProgesteroneCompleted · Phase 4 · Interventional · 20 enrolled · Wake Forest University Health SciencesNCT01959464updated 2022-04-22
- Hyaluronic Acid in Counteracting Aphthous StomatitisCompleted · Observational · 49 enrolled · University of Urbino "Carlo Bo"NCT04884464updated 2021-07-22
- Efficacy of Intravaginal Carboxymethyl-β-glucan and Polycarbophil on Low-grade Cervical Lesions (GLUCANCIN)Unknown · Interventional · 200 enrolled · Uriach Consumer HealthcareNCT04771546updated 2021-06-16
- Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV ClearanceUnknown · Interventional · 200 enrolled · Uriach Consumer HealthcareNCT04781023updated 2021-06-10
- Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066Completed · Phase 2 · Interventional · 54 enrolled · Novartis PharmaceuticalsNCT03198767updated 2021-01-05
- Evaluation of Viscosity of a Vaginal MoisturizerUnknown · Phase 4 · Interventional · 33 enrolled · Farmoquimica S.A.NCT03782961updated 2018-12-21
Frequently asked questions
- How does Calcium Polycarbophil work?
- Mechanism-of-action class: Stool Bulking Activity.
- What is Calcium Polycarbophil used for?
- According to FDA labeling, Calcium Polycarbophil carries indications including: USES relieves occasional constipation to help restore and maintain regularity this product generally produces bowel movement in 12 to 72 hours. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Calcium Polycarbophil?
- Calcium Polycarbophil is classified as Bulk-forming laxatives, Stool Bulking Activity, Increased Large Intestinal Motility, Inhibition Large Intestine Fluid/Electrolyte Absorption.
- What are the brand names for Calcium Polycarbophil?
- Calcium Polycarbophil is marketed under brand names including Equalactin, Fiber Tab, FiberCon.
calcium-polycarbophil is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.